Rethinking the definition of 'less intensive' for venetoclax-combining regimens in acute myeloid leukaemia patients

被引：0
作者：
Borlenghi, E. [1 ]
Roccaro, A. M. [2 ]
Cattaneo, C. [1 ,3 ]
机构：
[1] ASST Spedali Civili, Hematol, Brescia, Italy
[2] ASST Spedali Civili, Translat Res & Phase Unit 1, Clin Trial Ctr, Brescia, Italy
[3] ASST Spedali Civili, Hematol, I-25123 Brescia, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 203卷 / 04期
关键词：
acute myeloid leukaemia; invasive fungal infections; myelodysplastic syndromes; posaconazole; venetoclax;
D O I：
10.1111/bjh.19138
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Invasive fungal infections (IFIs), mainly due to pulmonary aspergillosis, are considered a serious complication in acute leukaemia, with an unfavourable impact on patient. In this well-conducted retrospective study, Reynolds et al. suggest that the use of posaconazole prophylaxis in association with venetoclax plus hypomethylating agents or chemotherapy leads to a reduction of IFI incidence. Therapeutic drug monitoring of posaconazole levels is suggested, even if no correlation with IFI risk has been demonstrated.
引用
收藏
页码：504 / 506
页数：3
相关论文
共 50 条
  • [41] Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia
    Lachowiez, Curtis A.
    Atluri, Himachandana
    DiNardo, Courtney D.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [42] Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients
    Petit, C.
    Saillard, C.
    Mohty, B.
    Hicheri, Y.
    Villetard, F.
    Maisano, V.
    Charbonnier, A.
    Rey, J.
    D'Incan, E.
    Rouzaud, C.
    Gelsi-Boyer, V.
    Murati, A.
    Lhoumeau, A. C.
    Ittel, A.
    Mozziconacci, M. J.
    Alary, A. S.
    Hospital, M. -A.
    Vey, N.
    Garciaz, S.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (04) : 530 - 537
  • [43] Long-term remission of extramedullary cutaneous relapse of acute myeloid leukaemia (leukaemia cutis) treated with decitabine-venetoclax
    Maravalle, Denise
    Filosa, Alessandra
    Bigazzi, Catia
    Collina, Guido
    Galieni, Piero
    EJHAEM, 2022, 3 (02): : 517 - 520
  • [44] Venetoclax Combining with Homoharringtonine,Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients
    Yan, Zhangsong
    Li, Yang
    Zhang, Bin
    He, Jinsong
    Li, Jiesi
    Wei, Shuning
    Wang, Qi
    Li, Qiuling
    Hu, Bo
    Liu, Kaiqi
    Mi, Yingchang
    BLOOD, 2023, 142
  • [45] Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia
    Takeshita, A
    Shinjo, K
    Izumi, M
    Ling, P
    Nakamura, S
    Naito, K
    Ohnishi, K
    Ohno, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (02) : 283 - 290
  • [46] Pneumocystis jirovecii pneumonia in patients with acute myeloid leukaemia
    Chang, Hung
    Kuo, Ming-Chung
    Lin, Tung-Liang
    Wu, Jin-Hou
    Wang, Po-Nan
    INTERNAL MEDICINE JOURNAL, 2018, 48 (01) : 81 - 83
  • [47] Optimising care for UK patients with acute myeloid leukaemia
    Pagliuca, Antonio
    Khwaja, Asim
    Dillon, Richard
    Evans, Paul A. S.
    Mohite, Unmesh
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2022, 83 (08)
  • [48] Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax plus hypomethylating agents
    Johnson, Isla M.
    Karrar, Omer
    Rana, Masooma
    Iftikhar, Moazah
    Chen, Sunny
    McCullough, Kristen
    Saliba, Antoine N.
    Al-Kali, Aref
    Alkhateeb, Hassan
    Begna, Kebede
    Litzow, Mark
    Hogan, William J.
    Shah, Mithun
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Hermann, Joerg
    Tefferi, Ayalew
    Gangat, Naseema
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1232 - 1237
  • [49] Baseline creatinine predicts acute kidney injury during intensive therapy in transplant-eligible patients with acute myeloid leukaemia
    Krieg, Stefan
    Seeger, Harald
    Hofmann, Patrick
    Del Prete, Carmen
    Manz, Markus G.
    Muller, Antonia M.
    Theocharides, Alexandre P. A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 781 - 784
  • [50] Cytogenetic and Molecular Drivers of Outcome with Venetoclax-Based Combination Therapies in Treatment-Naive Elderly Patients with Acute Myeloid Leukaemia
    Strickland, S.
    Chyla, B.
    Popovic, R.
    Bhathena, A.
    Dail, M.
    Sun, Y.
    Wei, A.
    Fiedler, W.
    Pratz, K.
    Hayslip, J.
    Potluri, J.
    DiNardo, C.
    Pollyea, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 159 - 159
12345